Thomas Riley

Professor, BAppSc Curtin, MAppEpid ANU, PhD W.Aust., FAAM, FASM, FRCPath, MAIMS

Professor, Faculty of Health and Medical Sciences, Infection and Immunity

Emailthomas.riley@uwa.edu.au

The University of Western Australia (M502), 35 Stirling Highway,
6009 Perth
Australia

12180 Citations
52 h-Index

If you made any changes in Pure these will be visible here soon.

Personal profile

Keywords

Anaerobic bacteriology
Antibiotics
Bacteria—antibiotic resistance
Bacteria—pathogenesis
Clostridium difficile
Diagnostic bacteriology
Infection control
Infectious diseases epidemiology
Infectious disease—alternative therapies
Infectious disease—animals, humans

Fingerprint Dive into the research topics where Thomas Riley is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

2 Similar Profiles

Clostridium difficile Medicine & Life Sciences

Tea Tree Oil Medicine & Life Sciences

Clostridium Infections Medicine & Life Sciences

Ribotyping Medicine & Life Sciences

Melaleuca Medicine & Life Sciences

Western Australia Medicine & Life Sciences

Polymerase Chain Reaction Medicine & Life Sciences

Volatile Oils Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1992 2019

3 Citations (Scopus)

An environmental cleaning bundle and health-care-associated infections in hospitals (REACH): a multicentre, randomised trial

Mitchell, B. G., Hall, L., White, N., Barnett, A. G., Halton, K., Paterson, D. L., Riley, T. V., Gardner, A., Page, K., Farrington, A., Gericke, C. A. & Graves, N., 1 Apr 2019, In : The Lancet Infectious Diseases. 19, 4, p. 410-418 9 p.

Research output: Contribution to journal › Article

Cross Infection

Multicenter Studies

Bacteremia

Infection

Touch

2 Citations (Scopus)

A series of three cases of severe Clostridium difficile infection in Australia associated with a binary toxin producing Glade 2 ribotype 251 strain

Wehrhahn, M. C., Keighley, C., Kurtovic, J., Knight, D. R., Hong, S., Hutton, M. L., Lyras, D., Wang, Q., Leong, R., Borody, T., Edye, M. & Riley, T. V., Feb 2019, In : Anaerobe. 55, p. 117-123 7 p.

Research output: Contribution to journal › Article

2 Citations (Scopus)

Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles: synthesis, antibacterial evaluation and preliminary mechanism of action studies

Tague, A. J., Putsathit, P., Hammer, K. A., Wales, S. M., Knight, D. R., Riley, T. V., Keller, P. A. & Pyne, S. G., 15 Apr 2019, In : European Journal of Medicinal Chemistry. 168, p. 386-404 19 p.

Research output: Contribution to journal › Article

Cationic biaryl 1,2,3-triazolyl peptidomimetic amphiphiles targeting Clostridioides (Clostridium) difficile: Synthesis, antibacterial evaluation and an in vivo C. difficile infection model

Tague, A. J., Putsathit, P., Hutton, M. L., Hammer, K. A., Wales, S. M., Knight, D. R., Riley, T. V., Lyras, D., Keller, P. A. & Pyne, S. G., 15 May 2019, In : European Journal of Medicinal Chemistry. 170, p. 203-224 22 p.

Research output: Contribution to journal › Article

Clostridium difficile ribotype 017-characterization, evolution and epidemiology of the dominant strain in Asia

Imwattana, K., Knight, D. R., Kullin, B., Collins, D. A., Putsathit, P., Kiratisin, P. & Riley, T. V., 29 May 2019, In : Emerging Microbes and Infections. 8, 1, p. 796-807 12 p.

Research output: Contribution to journal › Article

Open Access